Hero Technologies Inc. (OTCPK: HENC)
Health Care · Pharmaceuticals · US
$0.00
+9900.00% today · +9900.0% 1Y
Hero Technologies Inc. (OTCPK: HENC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $56.37K and employs 1 people.
Over the last twelve months the share price has gained 9900.0%, trading between 0.00 and 0.00.
Tweenvest scores Hero Technologies Inc. across four factors: quality 22/100. Its strongest factor is quality.
HENC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $56.37K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -31.40
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 563.69M
- Employees
- 1
- Next earnings
- —
About Hero Technologies Inc.
Hero Technologies Inc. functions as a nascent enterprise within the cannabis industry. Its primary focus is on the BlackBox, a proprietary aeroponic cannabis cultivation system. This cutting-edge system is engineered to create optimal growing conditions, thereby significantly boosting photosynthesis and enabling the development of robust flowering plants, which ultimately leads to more efficient harvests. Additionally, the company intends to expand its operations to include cannabis genetic engineering and providing farmland to support the full scope of medical and recreational cannabis activities, from cultivation and production to distribution, packaging, and retail operations, including dispensaries. The company was established in 2004 and is headquartered in Dover, Delaware.
- ISIN
- US42771W1080
- Listed since
- Feb 14, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.